Latest Breaking News On - Julie seidelstern investor relations inc - Page 1 : comparemela.com

Decibel Therapeutics to Participate in the Upcoming Guggenheim Healthcare Talks | Genomic Medicines and Rare Disease Days

Decibel Therapeutics to Participate in the Upcoming Guggenheim Healthcare Talks | Genomic Medicines and Rare Disease Days
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkLaurence reidDecibel therapeutics incJulie seidelstern investor relations incChief executive officerGuggenheim healthcare talksGenomic medicinesRare disease daysDecibel therapeuticsJulie seidelstern investor relationsChris raileyten bridge communications

Jounce Therapeutics (JNCE) Reports Results from Pre-Planned Data Review of INNATE Phase 2 Trial of JTX-8064 and Pimivalimab

Jounce Therapeutics (JNCE) Reports Results from Pre-Planned Data Review of INNATE Phase 2 Trial of JTX-8064 and Pimivalimab
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Richard murrayExchange commissionJulie seidelstern investor relations incKim drapkinjounce therapeutics incJounce therapeutics incWall streetOvarian cancer combination cohort respondersCombination cohort target lesionTranslational sciencePrivate securities litigation reform actAnnual reportMedia contactsKim drapkinjounce therapeuticsSeidelstern investor relationsJounce therapeutics